Bumetanide Tablet
FDA Label NDC 55154-3572

21 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Bumetanide (NDC 55154-3572). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning, description, clinical pharmacology, pediatric pharmacology, geriatric pharmacology, indications and usage, contraindications, warnings, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-3572-0

BUMETANIDE TABLETS, USP

1 MG

10 TABLETS

1mg Bag Label (F1163b02 1c88 49ab A34a 7646b61bb50e 00)

1mg Bag Label (F1163b02 1c88 49ab A34a 7646b61bb50e 00)

* Please review the disclaimer below.